More on Abaxis (ABAX): Q1 beats on a per share basis but misses on revenue, despite a 17% Y/Y...

|By:, SA News Editor

More on Abaxis (ABAX): Q1 beats on a per share basis but misses on revenue, despite a 17% Y/Y rise in total sales. Revenues from instruments +31%, consumables +12%, medical market sales -18%, medical sales worldwide, excluding sales to the U.S. government, -20%. Shares -5.8% AH.